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Summary
Streptomyces species are prolific producers of bioactive metabolites, such as b-lactone-
-containing lipstatin produced by Streptomyces toxytricini, an intermediate used in semi-
-synthetic process for production of anti-obesity drug orlistat. Understanding the distribu-
tion of identical or structurally similar molecules produced by a taxonomic group is of
particular importance when trying to isolate novel biologically active compounds or strains
producing known metabolites of medical importance with potentially improved proper-
ties. Until now, only two independent isolates of S. toxytricini species have been known to
be producers of lipstatin. According to the current taxonomic criteria, S. toxytricini belongs
to Streptomyces lavendulae phenotypic cluster. Taxonomy-based dereplication approach cou-
pled with in vitro assay was applied to screen the S. lavendulae phenotypic cluster for pro-
duction of lipstatin-like lipase inhibitors using synthetic p-nitrophenol derivatives of C4 and
C16 lipids. Screening the available strains from public collections belonging to S. lavendulae
phenotypic cluster, high lipase inhibitory activity was identified in the Streptomyces virgi-
niae CBS 314.55 culture supernatants. HPLC and LC-MS/MS confirmed lipstatin produc-
tion by a new Streptomyces species for the first time. We have demonstrated that the new
lipstatin-producing strain S. virginiae morphologically and physiologically differs from S.
toxytricini substantially; however, the production capacity of the newly identified lipsta-
tin-producing species S. virginiae is comparable to S. toxytricini. We have thus demonstrat-
ed the effectiveness of a simple and affordable dereplication approach for identification of
potentially novel and useful industrial strains available in public culture collections.
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Introduction
While it is still important to isolate and screen novel
species of Streptomyces for pharmaceutical and drug dis-
covery programmes, and prevent costly rediscovery of
known bioactive molecules (1), it is also important to fully
characterise known clades to understand distribution of
known bioactive metabolites and potentially find new
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structural or functional analogues. However, it is also of
great importance to identify new strains producing known
metabolites of industrial value with potentially improved
properties, such as higher yield of the target product, im-
proved purity profiles and other morphological or phys-
iological properties, as it was the case in the past during
the development of fermentation processes for produc-
tion of biologically active compounds such as penicillin
(2) and FK506 (3), where strains with advanced proper-
ties were introduced in order to improve the economy
and quality of final product. Discriminating between mi-
crobial isolates which are morphologically similar and
produce identical or similar metabolites is a particular
issue in the identification of specific novel biosynthetic
pathways in closely related strains, especially when con-
structing natural product libraries. Often referred to as
the 'dereplication issue', it is of particular significance
when dealing with Actinomycetes such as Streptomyces.
The genus currently contains 568 species (4); however,
this genus is still assumed underspeciated (5).
Lipstatin, and its medically important semisynthetic
analogue orlistat (Fig. 1a), is a member of a small group
of b-lactone-containing structures (Fig. 1a), which are ex-
clusively produced by Streptomyces toxytricini species
(6–10). The length of fatty acid moieties at the positions
R1 and R3 (Fig. 1b) and the origin of the amino acid-de-
rived residue attached to the hydroxyl group at the posi-
tion R2 determine the structure of this family of com-
pounds. Lipstatin irreversibly binds to pancreatic lipase
with an IC50 value of 0.14 mM and exhibits a dose-de-
pendent inhibition of triacylglycerol uptake in mice (11).
In its chemically reduced form, tetrahydrolipstatin (orli-
stat) is used to prevent obesity through the interference
with the degradation and absorption of lipid compounds
in the intestine (12). Therefore, novel lipstatin-like ana-
logues represent very interesting compounds with novel
therapeutic potential. Interestingly, all these b-lactone-con-
taining compounds reported in the literature are pro-
duced by the Streptomyces isolates belonging to the S.
lavendulae phenotypic cluster, including panclicins (13),
ebelactones A and B (9), valilactone (6), esterastin (8)
and lipstatin (14).
The S. lavendulae phenotypic cluster was first pro-
posed by Williams et al. (15), with many strains produc-
ing other commercially interesting metabolites such as
cycloserine (16), saframycin (17), and virginiamycin (18).
Attempts to resolve the complex taxonomy of this group
have been inconclusive, with the most interesting work
being that of Labeda (19), which evaluated and validat-
ed the specific status of 11 species as subjective syno-
nyms of S. lavendulae based on DNA relatedness.
The aim of this study is to screen selected members
of the S. lavendulae phenotypic cluster for alternative lip-
statin-producing strains. A taxonomy-related approach
was applied, where members of the S. lavendulae group
were selected and further screened for their ability to
produce metabolites capable of inhibiting porcine pan-
creatic lipase. Based on the dereplication approach, we
succeeded in identifying a previously unknown lipstatin
producer with novel morphological and physiological
properties. This study indicates that bioactive metabo-
lites still remain to be discovered in well-characterized
strains, and the dereplication of natural products is a
useful approach to finding novel strains with useful fer-
mentation characteristics.
Materials and Methods
Bacterial strains and growth conditions
The Streptomyces strains used in this study are sum-
marized in Table 1. All strains were grown on sporula-
tion agar (20). Plates were incubated at 28 °C for 14
days. Spore stocks were prepared according to Kieser et
al. (21).
Phylogenetic analysis
The 16S rRNA genes were downloaded from the
NCBI database (22) and they were aligned using Clus-
talW with phylogenetic reconstruction performed using
UPMGA and NJ methods in MEGA v. 4.0. The reliability
of these trees was estimated by bootstrapping with 1000
replicates (23). 16S rRNA sequence not available from
the database (See Table 1) was amplified by PCR, using
the universal 16S rRNA primers according to Lane (24)
and Muyzer et al. (25), followed by sequencing. The se-
quences were trimmed to identical lengths (1335 nt),
aligned and the trees were computed. Partial 16S rRNA
gene sequences were deposited in GenBank (accession
numbers: JN201950-JN201955).
Physiological characterization
Morphological and physiological differences between
Streptomyces toxytricini NRRL 15443 and Streptomyces vir-
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Fig. 1. Lipstatin and its medically important analogue orlistat (a). Basic structure of lipstatin-like metabolites containing typical
β-lactone group (b) where R1 and R3 represent aliphatic chains of fatty acids of different lengths and R2 represents various amino
acids or amino acid analogues attached through ester bonds to the hydroxyl group
giniae CBS 314.55 in carbon utilization were determined
using API ID 32 test (bioMérieux, Marcy l’Etoile, France).
The API test strip was inoculated with spore suspension
(106 spores/mL) and cultivated for three days.
Lipase inhibition assays
Inhibition of lipase activity by potential inhibitors
produced by the different strains in this study was de-
termined using two substrates, differing in aliphatic chain
length: p-nitrophenyl butyrate (pNPB) and p-nitrophenyl
palmitate (pNPP) (Sigma-Aldrich, St. Louis, MO, USA).
To test the lipase inhibition, fermentation broth extracts
were prepared by extracting with methanol in the ratio of
1:4 for 60 min. Samples were then centrifuged at 14 000
rpm for 10 min to remove cell debris and precipitates.
Extracts were then serially diluted in methanol, used in
lipase inhibition assay broth with the lipase from por-
cine pancreas (Sigma-Aldrich) and incubated with the
p-nitrophenyl substrates. Assays using 10 % (by volume)
pNPB in methanol were incubated in 3 mL of reaction
mixtures containing 2.93 mL of 0.1 M phosphate buffer
(pH=7.0), 25 mL of fermentation extract or 25 mL of H2O
(blank), and 30 mL of lipase (2.5 mg/mL prepared in 0.2
% Triton X-100). The reaction was started with 25 mL of
pNPB solution. When using 0.125 % pNPB in the ace-
tonitrile and ethanol ratio of 1:2, reactions were carried
out in 2-mL volumes containing 1.75 mL of Tris-HCl
(0.05 M, pH=8), 25 mL of fermentation extract or 25 mL of
H2O (blank), and 25 mL of lipase (2.5 mg/mL prepared
in 0.2 % Triton X-100). The reaction was started with 200
mL of pNPP solution. The release of p-nitrophenol was
measured spectrophotometrically at 400 nm for 10 min
at 37 °C. The percentage of lipase inhibition was calcu-
lated from the decrease in specific lipase activity com-
pared to the control sample (without the addition of cul-
ture extract) where molar absorption coefficient (e400 nm)
of pNPB was 14 800 M–1 cm–1 (26) and of pNPP it was 17
454 M–1 cm–1 (27).
HPLC analysis
Analysis of lipstatin production was carried out by
reversed phase HPLC using a C-18 column (150 mm×4.0
mm, particle size 3 mm, Inertsil®, GL Sciences BV, Eindho-
ven, The Netherlands) using acetonitrile and 0.1 % H3PO4
(75:25 by volume) as the mobile phase at a flow rate of
1.5 mL/min at 45 °C. Lipstatin peaks were detected at
200 nm and identified using lipstatin external standard
(obtained from Krka d.d., Novo Mesto, Slovenia).
LC-MS/MS analyses
LC-MS/MS analyses were performed on an Agilent
1100 with a reversed phase analytical C18 column (Gem-
ini C18 column, 5 ìm, 150 mm×2 mm i.d., Phenomenex,
Torrance, CA, USA). The separation (10 mL injection vol-
ume) was performed at a flow rate of 0.250 mL/min and
45 °C using gradient elution with 0.5 % TFA as solvent
A and acetonitrile as solvent B. The gradient program
was as follows: 20 % A, 0–13 min; 20–2 % A, 13–13.1
min; 2 % A, 13.1–23 min; 2–20 % A, 23–23.2 min; 20 %
A, 23.2–30 min.
The mass selective detector (Quattro Micro API, Wa-
ters, Milford, MA, USA) was equipped with an electro-
spray ionisation, and cone voltage of 20 V and capillary
voltage of 3.0 kV were used for positive ionisation of the
analytes. Dry nitrogen was heated to 350 °C and the dry-
ing gas flow was 8 L/min. Data were acquired in the
multi-reaction monitoring mode. The collision energy was
optimised for the following transitions: m/z=492.20>
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Streptomyces toxytricini NRRL 15443 DQ442548 lipstatin
Streptomyces lavendulocolor CBS 911.68 / NRRL B-3367 DQ442516 streptothricin complex
Streptomyces flavotricini CBS 259.66 N201955
Streptomyces goshikiensis CBS 835.68 / NRRL B05428 EF178693 bandamycin
Streptomyces subrutilus CBS 689.72 / NRRL B-12377 DQ442545 hydroxystreptomycin
Streptomyces racemochromogenes CBS 937.68 / NRRL B-5430 DQ026656 racemomycin
Streptomyces polychromogenes CBS 311.56 / NRRL 3032 AY999923 O-carbamyl-D-serine
Streptomyces katrae CBS 748.72 / NRRL 3093 EF654092
Streptomyces xanthophaeus CBS 572.68 / NRRL B5414 DQ442560 geomycin
Streptomyces virginiae CBS 314.55 / DSM 40094 JN201950 compound similar to streptogramin
Streptomyces lavendulae ssp. grasserius DSM 40385 AY999841 grasseriomycin
Streptomyces lavendulae ssp. lavendulae DSM 40558 / CBS 597.71 JN201953 vitamin B12
Streptomyces lavendulae ssp. lavendulae DSM 40708 JN201952 megacidin
Streptomyces lavendulae ssp. lavendulae DSM 40713 JN201951 ferrimycin (antibiotic A.9578)
Streptomyces lavendulae ssp. lavendulae DSM 41088 JN201954 streptothricin
NRRL=collection of the National Center for Agricultural Utilization Research, Peoria, IL, USA; CBS=CBS-KNAW Fungal Biodi-
versity Centre, Utrecht, The Netherlands; DSM=German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany
315.18 and 492.20>333.19. Dwell time for each transition
and inter-channel delay was optimized for high sensitiv-
ity.
Effect of nutrient source on lipstatin production in
S. virginiae CBS 314.55
Seed medium (10 g of soya bean flour, 20 g of glyc-
erol, 5 g of yeast extract per litre, pH=7) was aliquoted
in 50-mL volumes in 500-mL Erlenmeyer flasks and in-
oculated with S. virginiae CBS 314.55 spores (5·107 mL–1)
and incubated with shaking (28 °C, 210 rpm for 20–30
h). Aliquots of the above seed culture (10 % by volume)
were used to inoculate 50 mL of fermentation medium
in a 500-mL Erlenmeyer flask. Fermentation medium
contained the following: 20 g of glycerol, 14.3 g of leci-
thin (Evonik Degussa, Hanau, Germany), 2 g of CaCO3,
50 mL of soya bean oil, in 1 L of tap water (pH=7.2). The
addition of different concentrations of complex nitrogen
sources such as soya bean meal (Cargill, Conover, IA,
USA), tryptone (Merck, Darmstadt, Germany), cotton-
seed meal (ADM, Decatur, IL, USA), yeast (Ardamine
PH; Champlain Industries, Clifton, NJ, USA) and soya
peptone (Sigma-Aldrich) were tested in order to deter-
mine the effect of nitrogen sources on lipstatin produc-
tion. Lipstatin production process was carried out with
shaking at 28 °C and 210 rpm for 6 days (20). Apart
from the basic fermentation medium (with 4 % of soya
bean meal and 5 % of soya bean oil) described above,
supplementation with different mineral nitrogen sources
such as sodium glutamate, urea, (NH4)2SO4 and NH4Cl
(all from Sigma-Aldrich) were tested in the fermentation
medium to assess their effect on lipstatin production.
After optimization of nitrogen sources, different concen-
trations of soya bean oil were tested on lipstatin produc-
tion using the basic fermentation medium (containing 4
% of soya bean meal) described above.
Results and Discussion
Bacteria from genus Streptomyces are an important
source of industrially useful bioactive molecules, includ-
ing β-lactone metabolites, which inhibit esterase and li-
pase activity (6–8). A number of lipstatin-like β-lactone-
-containing compounds, produced almost exclusively by
Streptomyces species, have been reported in the literature
(6–10). However, most of the β-lactone-producing strains
have not been deposited in commercial culture collec-
tions and are thus not easily accessible. The focussed
taxonomy-based and inexpensive approach to test a se-
lected number of strains belonging to the Streptomyces
lavendulae phenotypic cluster was therefore carried out
as an approach to screen for novel structural and/or
functional analogues of known metabolites based on
phylogenetic relationships. Biosynthesis of lipstatin has
previously been reported from S. toxytricini (7,20), and
little is known about the production of β-lactone metab-
olites by other members of the S. lavendulae phenotypic
cluster.
Screening the Streptomyces lavendulae phenotypic
cluster for lipase activity
Three culture collections (CBS, NRRL and DSMZ)
were examined to identify Streptomyces species, which
were designated as belonging to the Streptomyces laven-
dulae phenotypic cluster (Table 1). A number of Strepto-
myces strains were deposited as independent isolates;
however, based on the phenotypic properties (e.g. pro-
duction of the identical secondary metabolite), a number
of target strains was refined. Finally, 15 strains were se-
lected, which were purchased from the corresponding
culture collections (Table 1). These strains were cultivat-
ed in basic fermentation medium containing vegetable
oil (Materials and Methods), which enhances the pro-
duction of lipstatin-like β-lactones. The lipase inhibitory
activity for each strain was evaluated using two esters of
p-nitrophenyl (pNP): pNPB and pNPP. Extracts from S.
toxytricini NRRL 15443 (the known lipstatin producer),
S. lavendulae ssp. lavendulae DSM 40558, S. racemochromo-
genes NRRL 5430 and S. virginiae CBS 314.55 showed sig-
nificant inhibitory action against C4 esters of pNP across
a range of dilutions (Table 2). However, screening of the
same extracts against the C16 esters of pNP showed that
fewer strains had a significant inhibitory activity; i.e. ex-
tracts from lipstatin producer S. toxytricini NRRL 15443
and extracts from S. virginiae CBS 314.55 (Table 2). The
extracts from S. lavendulae ssp. lavendulae DSM 40558 and
S. racemochromogenes NRRL 5430 did not inhibit the C16
activity of porcine pancreatic lipase in this assay.
Screening of a range of strains from the S. lavendulae
phenotypic cluster revealed limited lipase-inhibitory ac-
tivity against synthetic pNPP substrates (C16); however,
some activity was observed against synthetic pNPB sub-
strates (C4), suggesting that this group of organisms are
a potential source for identification of novel esterase and
lipase inhibitors. This disparity in activity between the
two substrates may reflect differences in the solubility
based on the aliphatic chains of the substrates. Weak
lipase inhibitory activity in the extracts of S. racemochro-
mogenes CBS 937.68 and S. lavendulae ssp. lavendulae DSM
40558 strains was observed. However, no inhibitory ac-
tivity was measured when using pNPP as substrate, sug-
gesting esterase activity. In the next stage, HPLC and
LC-MS/MS analyses of the selected strains with lipase-
-inhibitory activity were used for screening of the me-
tabolite corresponding to the mass of lipstatin.
Identification of a metabolite with lipase-inhibitory
activity in the culture extract of Streptomyces
virginiae CBS 314.55
Streptomyces toxytricini NRRL 15443 and Streptomyces
virginiae CBS 314.55 both displayed similar lipase inhibi-
tion profiles when screened against pNP synthetic sub-
strates (C4 and C16). HPLC analysis of the fermentation
broth of S. virginiae CBS 314.55, when compared against
authentic lipstatin standards and fermentation extracts
of S. toxytricini NRRL 15443, indicated the presence of a
metabolite with an identical retention time to lipstatin
(Fig. 2) and the structure was finally confirmed by LC-
-MS/MS. Methanol extracts of S. toxytricini NRRL 15443
and S. virginiae CBS 314.55 were compared by applying
two different chromatographic conditions using gradient
starting with 80 and 50 % acetonitrile (ACN) in the mo-
bile phase (Fig. 3), followed by MS/MS analysis that
monitored the following transitions: m/z=492.20>315.18
and 492.20>333.19. Both strains produced an identical
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metabolite (m/z=492; Fig. 3c), and identical fragmenta-
tion pattern to the commercial lipstatin standard con-
firmed by MS/MS spectra (daughter scan of 492.20 was
identical to 333 and 315; Fig. 3). Upon altering the chro-
matographic conditions from 80 to 50 % ACN, the reten-
tion time of lipstatin was altered identically in both
strains and in lipstatin standard. The ion mass fragmenta-
tion spectra were also identical for the metabolite produced
by both strains and the commercial standard confirming
the production of lipstatin by Streptomyces virginiae CBS
314.55.
Comparative taxonomical characterisation of
S. toxytricini and S. virginiae strains
Given the designated phylogenetic similarity between
Streptomyces toxytricini NRRL 15443 and Streptomyces vir-
giniae CBS 314.55, but substantially different physiological
and morphological properties, further characterization
of these two strains was undertaken to clarify the taxon-
omic relationship between them. The 16S rRNA se-
quences from the NCBI database for each of the strains
in Table 1 and sequencing of a 16S rRNA gene fragment
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Table 2. Lipase inhibitory activity of 16 strains belonging to the Streptomyces lavendulae phenotypic cluster determined using p-nitro-
phenyl butyrate (pNPB) and p-nitrophenyl palmitate (pNPP) as substrates. Activity is expressed as percentage of inhibition relative
to the control (no inhibition). Only strains with pNPP activity are shown. Streptomyces toxytricini and Streptomyces virginiae (bold)




1× 10× 100× 1000×
pNPB as substrate:
Streptomyces toxytricini NRRL 15443 93.2 92.6 88.8 76.4
Streptomyces lavendulocolor CBS 911.68/NRRL B3367 30.2 10.8 0.0 5.5
Streptomyces flavotricini CBS 259.66 42.8 15.2 8.8 0.0
Streptomyces goshikiensis CBS 835.68/NRRL B5428 4.8 0.0 0.0 5.0
Streptomyces subrutilus CBS 689.72/NRRL B12377 39.7 10.3 5.6 3.7
Streptomyces racemochromogenes CBS 937.68/NRRL B5430 37.0 19.4 21.5 23.0
Streptomyces polychromogenes CBS 311.56/NRRL 3032 16.7 6.4 2.9 9.3
Streptomyces katrae CBS 748.72/NRRL 3093 26.7 7.3 1.3 14.1
Streptomyces xanthophaeus CBS 572.68/NRRL B5414 23.6 0.0 0.0 0.0
Streptomyces virginiae CBS 314.55/DSM 40094 97.6 96.5 78.3 19.1
S. lavendulae ssp. lavendulae DSM 40385 21.8 11.8 19.3 14.0
S. lavendulae ssp. lavendulae DSM 40558/CBS 597.71 44.8 13.5 16.5 22.9
S. lavendulae ssp. lavendulae DSM 40708 31.5 5.0 0.0 8.1
S. lavendulae ssp. lavendulae DSM 40713 38.4 10.7 11.1 12.3
S. lavendulae ssp. lavendulae DSM 41088 23.1 19.2 0.0 0.0
pNPP as substrate:
Streptomyces toxytricini NRRL 15443 94.9 92.4 70.7 33.4
Streptomyces virginiae CBS 314.55/DSM 40094 89.2 73.3 70.7 14.7
Fig. 2. HPLC analysis of: a) commercial lipstatin standard, and fermentation broth of: b) Streptomyces toxytricini NRRL 15443 and c)
Streptomyces virginiae CBS 314.55 confirms the presence of lipstatin in the fermentation broth of S. virginiae
AU=arbitrary units
for the remaining isolates allowed the construction of
the phylogenetic tree (Fig. 4a), indicating a high degree
of relatedness between the two lipstatin-producing strains,
and the homogeneous nature of the Streptomyces la-
vendulae phenotypic cluster. Construction of the phylo-
genetic trees using either UMPGA or ML methods (23)
showed highly similar topologies indicating confidence
in the phylogeny. Our analysis has confirmed that, de-
spite significant morphological and physiological differ-
ences, both strains belong to the same S. lavendulae phe-
notypic cluster group, which is confirmed by the initial
designation in the culture collection.
Morphological and physiological characterisation of
Streptomyces virginiae CBS 314.55
Examining colony morphology of the two lipstatin-
-producing strains on sporulation medium showed sig-
nificantly different colony morphology (Fig. 4b). To ex-
amine the ability of the two strains to utilize a variety of
carbon sources, API ID 32 (bioMérieux) tests were used.
The differences between the two strains are summarised
in Table 3; the results of assimilation were identical when
using all other tested carbon sources. The newly identi-
fied S. virginiae strain displays entirely different colony
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Fig. 3. LC-MS/MS analysis of Streptomyces toxytricini NRRL 15443 and Streptomyces virginiae CBS 314.55 culture broths compared un-
der different chromatographic conditions: a) gradient starting with 80 % acetonitrile in the mobile phase, b) gradient starting with
50 % acetonitrile in the mobile phase, and c) MS fragment pattern of lipstatin peak at 7.49 min
AU=arbitrary units
Fig. 4. Phylogenetic analysis of strains belonging to the Streptomyces lavendulae phenotypic cluster used in this work (a). An UPMGA
tree (bootstrapped to 1000 replicates) based on the 16S rRNA indicates the close relationship of this cluster of species. Asterisks indicate
lipstatin-producing strains. Colony morphology and colour differences in the two lipstatin-producing strains indicating the variation in
the phenotypes of this cluster (b)
morphology on the agar plates, regarding the shape of
the colonies as well as pigmentation (Fig. 4b). In addi-
tion, the two strains differ also in the capacity of assimi-
lating five simple carbon sources, thus reflecting signifi-
cant physiological properties.
The effect of nutrient source on the production of
lipstatin by S. virginiae CBS 314.55
With the aim of examining the potential of S. vir-
giniae CBS 314.55 as an industrial lipstatin producer, our
experiments were based on industrial media previously
shown to be suitable for the production of lipstatin by S.
toxytricini strain (20). As demonstrated previously (28–
30), fatty acids are the main source of precursors for
lipstatin-like compounds and therefore significant yields
of these compounds can only be achieved by using fatty
acids (or vegetable oil) as a main source of carbon, as
demonstrated in recent publication by Luthra and Du-
bey (31), where production medium was optimized by
applying Plackett-Burman design, three factorial and one-
-variable-at-a-time approaches, where the effect of five
medium ingredients on lipstatin production was evalu-
ated, including glycerol, polypropylene glycol, soya bean
oil, soya lecithin and soya bean meal. Results clearly de-
monstrate that soya bean oil has the most pronounced
positive effect on the lipstatin production using S. toxy-
tricini ATCC 19813 as a production strain (31). Therefore,
the basic fermentation medium used in our experiments
contained 5 % of soya bean oil and was used to assess
the influence of nitrogen sources on the production of
lipstatin. Altering the provision of nitrogen sources in
the production medium (containing 5 % of soya bean oil
as the main carbon source) and its effect on lipstatin
production were examined using a range of complex ni-
trogen sources commonly used in industry. Additionally,
supplementation of a range of simple mineral sources of
nitrogen was also tested to examine their effect on lip-
statin production. Maximum lipstatin production (122
mg/L) was obtained in the production medium contain-
ing 40 g/L of soya bean meal, although comparable lipsta-
tin yields were also obtained using cottonseed meal and
soya peptone. Yeast extract and tryptone showed a signifi-
cantly reduced level of lipstatin production, suggesting
the repression of biosynthesis by these nitrogen sources
(Fig. 5a). Production medium containing 5 % of soya bean
oil and 40 g/L of soya bean meal was used to test the ef-
fect of supplementation of mineral nitrogen sources on
lipstatin production. Supplementation of the medium with
2.5 g/L of sodium glutamate slightly increased lipstatin
production (139 mg/L); however, higher concentrations
of sodium glutamate and the addition of urea or NH4Cl
significantly repressed lipstatin biosynthetic activity
(Fig. 5b).
Following the testing of different nitrogen sources,
effect of different fractions of soya bean oil was also ex-
amined. The provision of 1 to 10 % soya bean oil in pro-
duction medium as a carbon source showed that lip-
statin production was proportional to the soya bean oil
increase, where the final yield of 123 mg/L of lipstatin
was reached (Fig. 5c).
The highest yield of lipstatin achieved with S. vir-
giniae CBS 314.55 was over 120 mg/L, thus showing good
production capacity of the strain. In contrast, lipstatin
yield between 45–70 mg/L, using the same medium,
was achieved with S. toxytricini strain NRRL 15443.
Interesting difference between S. virginiae and S. toxy-
tricini was observed in relation to the influence of in-
creasing concentration of ammonium sulphate on lipsta-
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Table 3. Differences in the utilization of different carbon sources
on API ID 32 test (bioMérieux) between Streptomyces toxytricini













+ growth, – no growth
Fig. 5. The effect of carbon and nitrogen sources in the medium
on lipstatin production by Streptomyces virginiae: a) complex ni-
trogen sources using fermentation medium with 5 % of soya
bean oil, b) supplementation with simple/mineral nitrogen sour-
ces using fermentation medium containing 4 % of soya bean
meal and 5 % of soya bean oil, and c) effect of the addition of
different concentrations of soya bean oil. Error bars present
standard deviation from two independent biological replicates
tin production. Supplementation of the basic production
medium with different concentrations of (NH4)2SO4 signi-
ficantly repressed lipstatin production by S. virginiae strain,
but not by S. toxytricini. When using S. virginiae, the addi-
tion of 2 g/L of (NH4)2SO4 decreased lipstatin yield for
more than 50 % and further increase in (NH4)2SO4 con-
centrations reduced the yield of lipstatin for more than
five times. However, when using S. toxytricini strain, ini-
tial increase of (NH4)2SO4 displayed a positive effect on
lipstatin production (Fig. 6). Addition of 2 g/L of (NH4)2SO4
resulted in the highest lipstatin yield (157 mg/L) when
using S. toxytricini strain, where lipstatin production
was increased more than twice, compared to control.
Concentrations higher than 5 g/L of ammonium sulphate
showed negative effect on lipstatin production with both
strains. Thus, S. virginiae displayed higher nitrogen re-
pression phenotype with nitrogen as mineral source,
compared to S. toxytricini.
The composition of the industrial production me-
dium and how the bioprocess is carried out play a sig-
nificant role in terms of product yield, purity profile and
overall economy of the process (32). The use of vegeta-
ble oil in industrial fermentations is widespread and
vegetable oil is often used as a carbon source or, as in
our case, an important source of precursors for biosyn-
thesis of lipstatin (33–36). Linoleic acid is major compo-
nent of soya bean oil and therefore substrate for biosyn-
thesis of main C14 precursor (tetradeca-5,8-dienoic acid),
which is needed for lipstatin production. The provision
of rich organic nitrogen sources, such as cottonseed meal,
soya peptone and soya bean meal, exhibited significant
positive effects on lipstatin production in S. virginiae. It
has been shown that organic nitrogen sources, rich in
amino acids and peptides, can significantly affect carbon
source uptake in actinomycetes (37) or N-formyl-L-leu-
cine, which is derived from the amino acid leucine and
is also important biosynthetic precursor of lipstatin.
Similar observations were obtained by Luthra and
Dubey (31) using S. toxytricini ATCC 19813 strain, where
the highest lipstatin production was obtained in the me-
dium consisting of (in g/L): glycerol 22.5, soya bean
meal 35, soya bean oil 15, soya lecithin 25 and poly-
propylene glycol 0.5. In this study, soya bean oil, soya
lecithin and soya bean meal had significant effects on
lipstatin production.
Conclusions
This work has shown for the first time the capability
of S. virginiae CBS 314.55 to produce lipstatin. We have
demonstrated that it is possible to identify target com-
pound(s) produced by a new Streptomyces species after
careful analysis of the taxonomic data available on strains
from public culture collections using this affordable ap-
proach. Interestingly, the S. lavendulae group was diffi-
cult to resolve using 16S RNA methods alone, corrobo-
rating the work suggesting that secondary metabolic
capability may have a role in strain designation (19,38).
The identification of previously unknown lipstatin pro-
duction in S. virginiae CBS 314.55 highlights the impor-
tance of phylogenetic dereplication in the construction
of natural product libraries. The production of the same
or similar metabolites by related taxa is an issue that can
be potentially time and resource consuming in an indus-
trial context when a novel activity is being screened for.
However, dereplication can be useful when identifying
novel strains with potentially advanced physiological or
morphological properties.
Clearly, considering morphological and physiologi-
cal properties, and lipstatin productivity of these two
lipstatin-producing strains, S. virginiae CBS 314.55 strain
displays at least comparable (if not superior) properties.
Therefore, the newly identified lipstatin producer S. vir-
giniae shows potential for its industrial application. Nat-
urally, further work is needed to assess the properties
and potential advantages of S. virginiae in the industrial
settings and during process scale up.
It is most likely that many Streptomyces strains that
were screened for antibacterial activity in the 1950s and
1960s may produce metabolites of interest in a wider
medical context or are more tractable industrially. These
data suggest that dereplication and re-examination of
deposited strains can lead to affordable discoveries of
potentially useful industrial strains.
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